XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.1
DIRECTORS AND EMPLOYEES’ BENEFITS
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
DIRECTORS AND EMPLOYEES’ BENEFITS

14. DIRECTORS AND EMPLOYEES’ BENEFITS

 

Stock Option plans AEI

 

The Company previously reserved 500,000 shares of common stock under the Incentive Compensation Plan for high-quality executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its related entities. This plan is meant to enable such persons to acquire or increase a proprietary interest in the Company in order to strengthen the mutuality of interests between such persons and the Company’s shareholders, and providing such persons with performance incentives to expand their maximum efforts in the creation of shareholder value. As of March 31, 2022 and December 31, 2021, there have been no options granted. The reservation of shares under the Incentive Compensation Plan was cancelled in May of 2021.

 

Alset International Stock Option plans

 

On November 20, 2013, Alset International approved a Stock Option Plan (the “2013 Plan”). Employees, executive directors, and non-executive directors (including the independent directors) are eligible to participate in the 2013 Plan.

 

The following tables summarize stock option activity under the 2013 Plan for the three months ended March 31, 2021:

 

   Options for Common Shares   Exercise Price   Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding as of January 1, 2021   1,061,333   $0.09    3.00   $                     - 
Vested and exercisable at January 1, 2021   1,061,333   $0.09    3.00   $- 
Granted   -    -           
Exercised   -    -           
Forfeited, cancelled, expired   -    -           
Outstanding as of December 31, 2021   1,061,333   $0.09    2.00   $- 
Vested and exercisable at December 31, 2021   1,061,333   $0.09    2.00   $- 
Granted   -    -           
Exercised   -    -           
Forfeited, cancelled, expired   -    -           
Outstanding as of March 31, 2022   1,061,333   $0.09    1.75   $- 
Vested and exercisable at March 31, 2022   1,061,333   $0.09    1.75   $-